Allstate Corporation’s Bio-Rad Laboratories Class A BIO Stock Holding History

Allstate Corporation’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$981K	Buy	+3,340	New	+$947K	0.01%	762
2025 Q1	–	Sell	-621	Closed	-$204K	–	586
2024 Q4	$204K	Buy	+621	New	+$211K	0.01%	624
2022 Q4	–	Sell	-1,314	Closed	-$548K	–	583
2022 Q3	$548K	Sell	1,314 -21	-2%	-$10.5K	0.02%	468
2022 Q2	$661K	Sell	1,335 -1,098	-45%	-$572K	0.02%	436
2022 Q1	$1.37M	Sell	2,433 -1,650	-40%	-$995K	0.04%	328
2021 Q4	$3.08M	Buy	+4,083	New	+$3.06M	0.06%	292

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Allstate Corporation's BIO Position: Q2 2026 in Review

Allstate Corporation opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 3,340 shares worth $981K. The stake represents 0.01% of the portfolio and ranks #762 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in BIO as recently as Q4 2024.

Allstate Corporation first reported a position in BIO in Q4 2021 and has held it in 6 quarters since. The position peaked at $3.08M in Q4 2021. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Allstate Corporation held 3,340 shares of Bio-Rad Laboratories Class A worth $981K as of Q2 2026.
Bio-Rad Laboratories Class A was a new Allstate Corporation position in Q2 2026.
Bio-Rad Laboratories Class A made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #762 holding.
Allstate Corporation first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 6 quarters since.
Allstate Corporation's Bio-Rad Laboratories Class A position peaked at $3.08M in Q4 2021.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.